Lung Cancer Patient Journey Across the World: A Multidisciplinary Global Tumor Board

Overview

· The webinar will explore global differences in lung cancer management through multidisciplinary case discussions. Emphasizing policy and resource variability across regions, it will cover the full patient journey from diagnosis to survivorship, highlighting challenges like access to molecular testing, treatment affordability, and the influence of local healthcare infrastructure. The goal is to create an interactive, case-based dialogue that brings international perspectives on real-world clinical decision-making in diverse settings.

CME Accredited

Learning Objectives:
ACCME

At the end of the webinar, learners will be able to:

Understand the complexities involved in lung cancer care across the globe
Understand how resource-limited countries practice across the globe.
Analyze multidisciplinary approaches in diverse settings.
Apply clinical insights from case-based discussions and treat patients with a more holistic perspective.
Identify opportunities for global collaboration.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.

The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Learning Objectives:

At the end of the webinar, learners will be able to:

Understand the complexities involved in lung cancer care across the globe
Understand how resource-limited countries practice across the globe.
Analyze multidisciplinary approaches in diverse settings.
Apply clinical insights from case-based discussions and treat patients with a more holistic perspective.
Identify opportunities for global collaboration.

ACCME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.

The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.